Glenmede Trust CO Na Charles River Laboratories International, Inc. Transaction History
Glenmede Trust CO Na
- $20.6 Billion
- Q3 2024
A detailed history of Glenmede Trust CO Na transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Glenmede Trust CO Na holds 1,210 shares of CRL stock, worth $220,401. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,210
Previous 1,105
9.5%
Holding current value
$220,401
Previous $228,000
4.39%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding CRL
# of Institutions
695Shares Held
52.2MCall Options Held
259KPut Options Held
463K-
Vanguard Group Inc Valley Forge, PA6.1MShares$1.11 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$927 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.74MShares$681 Million0.13% of portfolio
-
State Street Corp Boston, MA2.13MShares$388 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.94MShares$353 Million0.87% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $9.26B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...